Transcriptomic profiling of insulinomas reveals a new “low-endocrine” subtype with low YY1 expressions
Pancreatology · 2026
DOI: 10.1016/j.pan.2026.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2026. Verfasst von Yongzheng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Ch…. Hauptthemen laut MEDLINE: Insulinoma, YY1 Transcription Factor, Pancreatic Neoplasms. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Insulinoma is the most common functional pancreatic neuroendocrine tumors, typically originating from pancreatic β cells. However, the transcriptional heterogeneity and the regulatory role of transcription factor YY1 remain incompletely understood. METHODS: High-throughput bulk-RNA sequencing was conducted on insulinoma tumor samples. Unsupervised clustering algorithms were employed to identify molecular subtypes of insulinomas. YY1 mutation status was analyzed by whole-exome sequencing. Functional roles of YY1 were analyzed by Yy1-overexpression and knockdown in INS-1 cell line. Spatial transcriptomic characteristics of insulinoma were analyzed using Visium HD platform. RESULTS: Transcriptomic analysis identified two distinct expression patterns: a low-endocrine subtype and an endocrine subtype. The low-endocrine subtype was characterized by reduced PDX1 and insulin synthesis pathways, with an enrichment in exocrine-related functions. However, these two subtypes exhibited similar clinicopathological features. Notably, while YY1 mutation rates were comparable between the two subtypes, YY1 expression levels were significantly reduced in the low-endocrine subtype. Functional experiments demonstrated that Yy1 levels directly correlated with insulin production, as Yy1 overexpression in INS-1 cells markedly upregulated insulin processing genes and secretory pathways. Yy1 knockdown led to suppression of insulin. Furthermore, spatial transcriptomics confirmed that low-endocrine subtype possessed reduced insulin scores compared to the endocrine subtype. CONCLUSION: We found a low-endocrine subtype insulinoma with reduced YY1 expression and insulin synthesis transcriptomic signature. This highlights the transcriptomic heterogeneity of insulinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Clinical Biobank, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; State Key Laboratory of Complex Severe and Rare Diseases, Peking…
Zitieren
APA
Li, Y., Zhang, X., Xu, Q., Han, X., Guo, D., Jiao, Y., Zhang, H., Yin, B., Hong, X., & Wu, W. (2026). Transcriptomic profiling of insulinomas reveals a new “low-endocrine” subtype with low YY1 expressions. Pancreatology. https://doi.org/10.1016/j.pan.2026.02.006
Vancouver
Li Y, Zhang X, Xu Q, Han X, Guo D, Jiao Y, et al. Transcriptomic profiling of insulinomas reveals a new “low-endocrine” subtype with low YY1 expressions. Pancreatology. 2026. doi:10.1016/j.pan.2026.02.006
BibTeX
@article{Li2026,
author = {Li, Yongzheng and Zhang, Xingwu and Xu, Qiang and Han, Xianlin and Guo, Dan and Jiao, Yixi and Zhang, Hao and Yin, Bohui and Hong, Xiafei and Wu, Wenming},
title = {Transcriptomic profiling of insulinomas reveals a new “low-endocrine” subtype with low YY1 expressions},
journal = {Pancreatology},
year = {2026},
doi = {10.1016/j.pan.2026.02.006}
}
EUVIMED